Literature DB >> 21825216

Neurological injury in adults treated with extracorporeal membrane oxygenation.

Farrah J Mateen1, Rajanandini Muralidharan, Russell T Shinohara, Joseph E Parisi, Gregory J Schears, Eelco F M Wijdicks.   

Abstract

BACKGROUND: Extracorporeal membrane oxygenation (ECMO) may be urgently used as a last resort form of life support when all other treatment options for potentially reversible cardiopulmonary injury have failed.
OBJECTIVE: To examine the range and frequency of neurological injury in ECMO-treated adults.
DESIGN: Retrospective clinicopathological cohort study.
SETTING: Mayo Clinic, Rochester, Minnesota. PATIENTS: A prospectively collected registry of all patients 15 years or older treated with ECMO for 12 or more hours from January 2002 to April 2010. INTERVENTION: Patients were analyzed for potential risk factors for neurological events and death using logistic regression and Cox proportional hazards models. MAIN OUTCOME MEASURES: Neurological diagnosis and/or death.
RESULTS: A total of 87 adults were treated (35 female [40%]; median age, 54 years [interquartile range, 31]; mean duration of ECMO, 91 hours [interquartile range, 100]; overall survival >7 days after ECMO, 52%). Neurological events occurred in 42 patients who received ECMO (50%; 95% confidence interval [CI], 39%-61%). Diagnoses included subarachnoid hemorrhage, ischemic watershed infarctions, hypoxic-ischemic encephalopathy, unexplained coma, and brain death. Death in patients who received ECMO who did not require antecedent cardiopulmonary resuscitation was associated with increased age (odds ratio, 1.24 per decade; 95% CI, 1.03-1.50; P = .02) and lower minimum arterial oxygen pressure (odds ratio, 0.79; 95% CI, 0.68-0.92; P = .03). Although stroke was rarely diagnosed clinically, 9 of 10 brains studied at autopsy demonstrated hypoxic-ischemic and hemorrhagic lesions of vascular origin.
CONCLUSION: Severe neurological sequelae occur frequently in adult ECMO-treated patients with otherwise reversible cardiopulmonary injury (conservative estimate, 50%) and include a range of potentially fatal neurological diagnoses that may be due to the precipitating event and/or ECMO treatment.

Entities:  

Mesh:

Year:  2011        PMID: 21825216      PMCID: PMC7816483          DOI: 10.1001/archneurol.2011.209

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  49 in total

1.  Neuroimaging Findings in Patients with COVID-19.

Authors:  P Nicholson; L Alshafai; T Krings
Journal:  AJNR Am J Neuroradiol       Date:  2020-06-11       Impact factor: 3.825

2.  Neurological Prognostication of Cardiac Arrest in an Era of Extracorporeal Membrane Oxygenation.

Authors:  Supreet K Sahai; Tamara Majic; Jignesh Patel; Michael Nurok; Asma M Moheet; Axel J Rosengart; Shouri Lahiri
Journal:  Neurohospitalist       Date:  2016-05-11

Review 3.  Extracorporeal membranous oxygenation (ECMO) in polytrauma: what the radiologist needs to know.

Authors:  David Dreizin; Jay Menaker; Thomas M Scalea
Journal:  Emerg Radiol       Date:  2015-06-06

4.  Gas Transfer in Cellularized Collagen-Membrane Gas Exchange Devices.

Authors:  Justin H Lo; Erik K Bassett; Elliot J N Penson; David M Hoganson; Joseph P Vacanti
Journal:  Tissue Eng Part A       Date:  2015-07-16       Impact factor: 3.845

5.  Intracranial hemorrhage during extracorporeal membrane oxygenation: does family history play a role?

Authors:  Gennaro Martucci; Vincenzina Lo Re; Gianluca Marrone; Settimo Caruso; Antonio Arcadipane
Journal:  Neurol Sci       Date:  2015-03-31       Impact factor: 3.307

6.  Determinants of survival and favorable neurologic outcomes in ischemic heart disease treated by veno-arterial extracorporeal membrane oxygenation.

Authors:  Keisuke Yonezu; Kenichi Sakakura; Yusuke Watanabe; Yousuke Taniguchi; Kei Yamamoto; Hiroshi Wada; Shin-Ichi Momomura; Hideo Fujita
Journal:  Heart Vessels       Date:  2017-08-03       Impact factor: 2.037

7.  Association of Cerebral Oximetry with Outcomes after Extracorporeal Membrane Oxygenation.

Authors:  Po-Yang Tsou; Alejandro V Garcia; Alvin Yiu; Dhananjay M Vaidya; Melania M Bembea
Journal:  Neurocrit Care       Date:  2020-10       Impact factor: 3.210

Review 8.  Extra Corporeal Membrane Oxygenation (ECMO) review of a lifesaving technology.

Authors:  George Makdisi; I-Wen Wang
Journal:  J Thorac Dis       Date:  2015-07       Impact factor: 2.895

9.  Bivalirudin in venovenous extracorporeal membrane oxygenation.

Authors:  Aman Jyoti; Arun Maheshwari; Elvin Daniel; Amit Motihar; Rajpal Singh Bhathiwal; Deevakar Sharma
Journal:  J Extra Corpor Technol       Date:  2014-03

10.  Apnea test for brain death determination in a patient on extracorporeal membrane oxygenation.

Authors:  Pierre Smilevitch; Laurent Lonjaret; Olivier Fourcade; Thomas Geeraerts
Journal:  Neurocrit Care       Date:  2013-10       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.